Neil Reisman Mirati Therapeutics, Inc

As of April 8, 2019


Neil Reisman Net Worth

  • Net worth is estimated to be at least $4.6M
  • Owns at least 522,496 units of Mirati Therapeutics, Inc stock
  • Sold an estimated value of $339.54K in the last 2 years at Mirati Therapeutics, Inc

Neil Reisman Trading

  • Largest purchase of shares was 286,163 units , worth over $1.6M on January 10, 2017
  • In total has made about 6 transactions over 2 years
  • Usually trades in January, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Neil Reisman Mailing Address

  • Mailing address is 11682 el Camino Real, Suite 320 San Diego CA 92130 CA

Mirati Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Charles M. Baum, M.D., Ph.D. 2020 $615,013 $6,092,158 $498,161 $498,161 $14,250 $11,747,582
Charles M. Baum, M.D., Ph.D. 2019 $597,100 $7,474,287 $410,506 $410,506 $2,500 $8,484,393
Charles M. Baum, M.D., Ph.D. 2018 $579,700 $3,851,079 $434,800 $434,800 $2,500 $4,868,079
James Christensen, Ph.D. 2020 $500,000 $2,379,745 $303,750 $303,750 $16,301 $6,988,546
James Christensen, Ph.D. 2019 $435,000 $2,637,984 $217,500 $217,500 $2,500 $3,292,984
James Christensen, Ph.D. 2018 $374,385 $2,571,375 $247,200 $247,200 $2,500 $3,195,460
Daniel Faga 2020 $494,231 $4,999,987 $303,750 $303,750 $362,373 $9,160,360
Benjamin Hickey 2020 $484,346 $2,499,988 $297,675 $297,675 $16,296 $5,798,359
Jamie A. Donadio 2020 $1,439 $ $ $ $422,122 $423,561
Jamie A. Donadio 2019 $373,900 $2,637,984 $186,950 $186,950 $2,500 $3,201,334
Jamie A. Donadio 2018 $363,000 $1,040,832 $217,800 $217,800 $2,500 $1,624,132
Isan Chen, M.D. 2020 $198,676 $ $ $ $485,281 $683,957
Isan Chen, M.D. 2019 $433,100 $2,637,984 $216,550 $216,550 $2,500 $3,290,134
Isan Chen, M.D. 2018 $420,500 $1,040,832 $252,300 $252,300 $2,500 $1,716,132
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021007114/mirati2021proxy.htm

Mirati Therapeutics, Inc Insider Trading

  • The most recent transaction was 40,000 units sold on June 21, 2021 by Charles Baum worth over $6.62M
  • In the last 8 years, insiders at Mirati Therapeutics, Inc sold an estimated value of $596.72M and bought an estimated value of $130.49M
  • The most active traders are Charles Baum, President & CEO,  Jamie Christensen, EVP,  and Braslyn Ltd
  • Insider trading is most common in January, with the busiest year in 2019

Mirati Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1